PFAS Removals and Increases in the Effluent of Thirteen New Hampshire Wastewater Treatment Facilities Due to the Effects of Biological Treatment Processes by Harvell, Zachary P.
University of New Hampshire 
University of New Hampshire Scholars' Repository 
Honors Theses and Capstones Student Scholarship 
Spring 2020 
PFAS Removals and Increases in the Effluent of Thirteen New 
Hampshire Wastewater Treatment Facilities Due to the Effects of 
Biological Treatment Processes 
Zachary P. Harvell 
University of New Hampshire, Durham 
Follow this and additional works at: https://scholars.unh.edu/honors 
 Part of the Environmental Engineering Commons 
Recommended Citation 
Harvell, Zachary P., "PFAS Removals and Increases in the Effluent of Thirteen New Hampshire Wastewater 
Treatment Facilities Due to the Effects of Biological Treatment Processes" (2020). Honors Theses and 
Capstones. 544. 
https://scholars.unh.edu/honors/544 
This Senior Honors Thesis is brought to you for free and open access by the Student Scholarship at University of 
New Hampshire Scholars' Repository. It has been accepted for inclusion in Honors Theses and Capstones by an 




PFAS Removals and Increases in the Effluent of Thirteen New Hampshire Wastewater 




Environmental Engineering, University of New Hampshire 
 
 













1.1. Project Motivation: Perfluoroalkyl substances, or PFAS, are an emerging contaminant of 
concern in environmental engineering. This group of chemicals has been used by manufacturers 
since the 1940s due to their desirable waterproofing qualities. They also have a high chemical 
stability at high temperatures, which makes treatment difficult. A large variety of manufactured 
items contain PFAS, such as fabrics and apparel, non-stick items, and food wrappers. Recently, 
these compounds have come under question due to studies supporting harmful health effects, 
such as low birthweight, cancer, thyroid hormone disruption, and a weakened immune system. 
Due to their chemical structure, PFAS compounds are difficult to treat for, but some methods 
are available. Current treatment and transformation processes for PFAS include activated 
carbon sorption, oxidation, reduction with aqueous iodide or dithionate and sulfate, thermal 
destruction or degradation, microbial treatment, and others such as ozonation (Merino et al., 
2016). Microbial treatment can occur during biological treatment in wastewater treatment 
plants and can vary depending on the processes used. PFAS compounds can enter the 
wastewater system from a variety of sources and undergo biodegradation before being 
distributed between effluent and sludge. This study will aim to examine how different 
biological treatment processes impact PFAS removal and effluent concentrations. 
 
1.2. Background: PFAS compounds enter the wastewater system from industries, household 
products and clothing, and from the environment through runoff and groundwater. Another 
source is landfill leachate, which contains large concentrations of PFAS due to the many 
products that contain or used to contain them being discarded. Not all wastewater treatment 
plants accept landfill leachate, so the previous statement only applies to those that do. In many 
past studies, such as the following one, it has been shown that PFOA and PFOS concentrations 
increase between influent and effluent due to the degradation compounds during treatment 
processes. In biological treatment, microbes break down polyfluoroalkyl substances into 
perfluoroalkyl ones, which explains the concentration increase between influent and effluent 
(Merino et al., 2016).  
A 2005 study by Wang et al. observed the effects of biotransformation on 8:2 FTOH in a 
series of bottles with bacterial cultures mixed with activated sludge in aerobic and anaerobic 
environments (Sáez et al., 2008). Results supported that the 8:2 FTOH was ultimately being 
biodegraded into PFOA using the byproduct 7:3 FTCA as a substrate for beta oxidation (Butt et 
al., 2014). PFOA can then further degrade into short-chain compounds, such as HFBA, PFPeA, 
PFHxA, and PFHpA. PFOS can degrade into PFBS and HFBA (Huang and Jaffé, 2019). These 
results support the previously proposed statement that activated sludge systems biodegrade 
polyfluoroalkyl substances to perfluoroalkyl ones. An analysis done on 19 Australian WWTPs 
found that there was an increase in PFPeA, PFHxA, PFHpA, PFOA, PFNA, and PFDA from influent 
to effluent (Coggan et al., 2019). This statement supports the biodegradation pathway of PFOA 
as a determinant of PFAS compounds present in wastewater effluent. Most of the plants 
studied were activated sludge, with 6 being lagoon systems. After the treatment process, the 
remaining PFAS compounds are separated into sludge and effluent. This separation is due to 
the hydrophobicity and hydrophilicity of various species of PFAS. The hydrophobic long-chain 
PFAS compounds are attracted to sludge as they are repelled by water, while the hydrophilic 
short-chain PFAS compounds are attracted to water and remain in the effluent.  
This study will aim to analyze the WWTP influent and effluent PFAS concentration data 
for the state of New Hampshire taken in 2017 for how different biological treatment methods 
impact removal of seventeen PFAS compounds. The data will also be compared to the Great 
Bay dataset collected by Ellie Tavasoli to determine whether the data patterns agree. There is 
no overlap in treatment plants observed between the two data sets.  
 
1.3. Research Questions: 
1. Do the New Hampshire WWTPs show a pattern of increasing PFAS concentrations from 
influent to effluent? Are there any noticeable patterns/trends in the data? 
2. How does removal for different PFAS species differ based on the biological treatment 
method used? How do variations effect the removal (leachate, seasons, etc.)? 
3. How do the trends in the New Hampshire data compare to the Great Bay data collected by 
Ellie Tavasoli? Do they agree?  
 
1.4. Approach: Information will be collected from each of the state surveyed plants to 
determine the biological treatment process used at each plant to be used in the analysis. Once 
compiled, the data will be analyzed and compared to assess whether certain treatment 
processes may influence the PFAS removal between sites and how that will impact the effluent 
PFAS concentrations. The operators of each of the state WWTPs will need to be contacted in 
order to learn what biological process each plant is using. Once the treatment processes are 
known, the state dataset will be able to be grouped and analyzed for PFAS removal by 
treatment process and PFAS species.  
 
1.5. Expected Outcome: It is expected that there will be noticeable patterns in the state 
dataset, such as an increase in PFAS concentrations from influent to effluent, and that they will 
be similar to those seen in the Great Bay. It is also expected that different processes will impact 
different PFAS compounds, and that that process will be affected based on factors like leachate 
acceptation and time of year sampled.  
Table 1.1: List of studied PFAS species with their chemical name 
Abbreviation Chemical Name 
8:2 FTOH 6:2 Fluorotelomer alcohol 
PFOS Perfluorooctanesulfonic acid 
PFOA Perfluorooctanoic acid 
7:3 FTCA 7:3 Fluorotelomer carboxylic acid 
HFBA Heptafluorobutyric acid 
PFPeA Perfluoropentanoic acid 
PFHxA Perfluorohexanoic acid 
PFHpA Perfluoroheptanoic acid 
PFBS Perfluorobutanesulfonic acid 
PFNA Perfluorononanoic acid 





In this analysis, influent and effluent concentrations of 17 PFAS compounds (TABLE) 
from 13 wastewater treatment plants in New Hampshire were compared. There was also The 
dataset(TABLE A.3.1), which came from the New Hampshire Department of Environmental 
Services wastewater division . Before importing data into JMP, it was prepared using excel. 
First, another dataset from NHDES which listed the secondary treatment and disinfection used 
at each facility in the state was used to determine which secondary treatment and disinfection 
processes were used by the 13 facilities in the study. This information was added in a column to 
the PFAS concentration dataset so the data could be analyzed for significance by treatment 
process in JMP. Next, the dataset was separated into 2 tables. Table one had influent and 
effluent concentrations of each facility. Table two had the difference between the influent and 
effluent concentrations was compared by treatment type. 
The two prepared data tables were imported into the JMP application, where statistical 
tests were run to determine if there were significant differences in the concentration of each 
PFAS species by sampling location and secondary treatment type. In JMP, values that had 
undetected concentrations were omitted. For data table one, influent vs. effluent, an ANOVA 
test and t test were run with the PFAS compound as the response and the sampling location as 
the independent variable. The sample means and p-values for each of these tests were 
recorded and are displayed in Table 3.1. A Wilcoxon test was also run to determine if the 
sample means were significantly different between the influent and effluent, and the p-values 
are also displayed in Table 3.1.  
The same tests were run for the difference table using PFAS concentration as a response 
and secondary treatment type as the independent variable. The p-values and means of each of 
these tests are displayed in Table 3.2. Average concentration plots were made for each PFAS 
compound comparing the sample means of the influent and the effluent. 
3. RESULTS 
3.1 Sample Location 
The results of each of the tests by sampling location are shown in Table 3.1. Figure 3.1.1 
shows the average concentrations of each PFAS species, but together in one graph. Figures 
3.1.2-3.1.12 show average concentration plots of the influent and effluent for each PFAS 













Table 3.1: Influent and Effluent PFAS concentrations for each PFAS species studied 
Influent and Effluent by sample location 











Compound       
PFBA 0.904 20.78 22.36 18.74 25.17 0.872 
PFPeA 0.697 26.22 31.97 34.38 32.35 0.778 
PFHxA 0.0447 14.48 45.83 12.76 51.64 0.034 
PFHpA 0.366 10.05 14.45 4.14 6.68 0.479 
PFOA 0.882 15.87 17 18.03 17.33 0.469 
PFNA - - 3.43 - 1.19 - 
PFDA - - 4.45 - - - 
PFUnA - - - - - - 
PFDoA - - - - - - 
PFTrDA - - - - - - 
PFTeDA - - - - - - 
PFBS 0.589 4.67 4.13 0.713 1.47 1 
PFHxS 0.609 8.43 7.24 4.57 2.06 0.916 
PFOS 0.652 10.18 11.47 6.51 5.44 0.507 
PFDS - - - - - - 
6:2 FTS - 31.6 13.4 - - 0.317 
PFOSA - - -   - 
Total NH regulated 0.823 23.72 25.65 22.69 20.75 0.857 





























Influent vs. Effluent Concentrations for all 
measured PFAS




















































































Figure 3.1.4: Sample means of the influent and effluent PFHxA concentrations. This was the only 







































































































































































































































Figure 3.1.11: Sample means of the influent and effluent concentrations of the total of the four 



























































Table _: Change in PFAS concentrations by treatment process 
 
 
Figure 3.1.12: Sample means of the influent and effluent total PFAS concentrations 
3.2. Treatment Process 
The results of each of the tests by treatment process are shown in Table 3.2. Figure 3.2 shows 
































Table 3.2.1: The change in PFAS concentrations by the four treatment types (aerated lagoon, 

































Compound         
PFBA 0.974 5.47 5.2 - - 7.05 11.92 0.827 
PFPeA 0.855 -4.56 22.26 9.64 2.8 72.12 34.05 0.736 
PFHxA 0.882 29.6 38.01 20.26 4.5 15.84 50.59 0.56 
PFHpA 0.707 9.5 4.32 - - 14.28 9.08 0.438 
PFOA 0.37 5.86 2.53 6.72 1.34 4.09 3.13 0.344 
PFNA - 3.43 - - - 1.19  - 
PFDA - - - - -   - 
PFUnA - - - - -   - 
PFDoA - - - - -   - 
PFTrDA - - - - -   - 
PFTeDA - - - - -   - 
PFBS 0.266 1.5 -3.14 4.73 - 0.69 4.04 0.165 
PFHxS 0.206 -4.6 -0.57 - - 3.19 2.79 0.165 
PFOS 0.832 -3.97 -1.87 - -7 7.99 8.79 0.809 
PFDS - - - - -   - 
6:2 FTS - - - - -   - 
PFOSA - - - - -   - 
Total NH 
regulated 0.892 -1.05 0.76 -2.88 -5.66 5.22 9.84 0.847 
Total PFAS 0.829 33.68 64.32 9.15 1.64 72.98 89.57 0.646 
 
Figure 3.2: Change in PFAS concentrations by treatment process 
3.3. Tavasoli study 
The results of a similar experiment done in the Great Bay by Elham Tavasoli are shown below in 
Table 3.1.1. Another table was produced in the same style for this study, which is shown below 
in Tables 3.3.2 and 3.3.3.  Both tables list the PFAS compound, whether it is detected in the 
influent at each location, and if it increases or decreases in the effluent. The Great Bay study 
took a march and July sample, while NHDES took a single influent and effluent sample at each 
plant, taking place between April and August with most of them occurring in June. The six plant 
in the Great Bay study were one of four secondary treatment types: oxidation ditch, aerated 
lagoon, a bardenpho process, and activated sludge. There were also two types of disinfection 
used, chlorination and dechlorination, and ultraviolet. The four types observed in this study 
were activated sludge, activated biofilter, aerated lagoon, and extended air. The two 































Change in concentration of each PFAS species by 
treatment process
AL mean AS Mean EA mean ABF mean
Table 3.3.1: Table from Elham Tavasoli’s study in the Great Bay depicting PFAS detections at six 
WWTPs. Grey indicates detection of the compound in the influent, red indicates a concentration 










Table 3.3.2: PFAS detection table for the first 7 of the 13 WWTPS studied. The colors indicate the 
same as the table for the Great Bay study, and green indicates that there was no change 

















































































Table 3.3.3: PFAS detection table for the remaining 6 of the 13 WWTPS studied. The colors 
indicate the same as the table for the Great Bay study, and green indicates that there was no 




Only PFHXA by sampling location was shown to be significantly different with a p value of .0447. 
Shown above in Table 3.1. No other tests for sampling location were significant.  No compounds 
were significant for change in concentration by treatment type. While every test besides 
sampling location for PFXHA showed that there was no significant difference between the 
influent and effluent or by secondary treatment type, the effluent still showed a higher sample 
mean, indicating that there is an overall increase in PFAS concentration. For the secondary 
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treatment type, there was an insufficient amount of data points to confidently determine 
whether there was a significant difference. It is possible that with a larger set of data points, 
new significant relationships could appear if the same tests were run again. 
4.2. PFHxA Significance 
PFHXA by sampling location, the only significant test, had an influent mean concentration of 
14.45 ng/L and the effluent mean concentration was 45.83ng/L. The standard deviations were 
12.76 and 51.64 for influent and effluent respectively, which indicates that each of the plants 
had highly varying PFHxA concentration values, especially in the effluent. One explanation for 
this variation may be the treatment type of the facility; however, the test for concentration 
change by treatment type for PFHxA was not significant. Again, the test may have been 
significant with a larger dataset, which should be further investigated. 
It was expected that several of the PFAS compounds would see a significant increase between 
influent and effluent, and that treatment type would also show significance. While this was not 
the case, aside from the single significant test for PFHxA by sampling location, the sample mean 
concentrations increased from influent to effluent, with only PFBS, PFHxS, and 6:2 FTS showing 
a decrease. It is possible that with a larger dataset, more compounds would exhibit a significant 
difference or increase from influent to effluent. Likely reasoning for the increases observed is 
that microbes in the biological treatment process break down polyfluoroalkyl compounds into 
perfluoroalkyl ones (Merino et al., 2016).   
A 2005 study by Wang et al., which observed the effects of biotransformation on 8:2 
FTOH in a series of bottles with bacterial cultures mixed with activated sludge in aerobic and 
anaerobic environments, supported that the 8:2 FTOH was ultimately being biodegraded into 
PFOA using the byproduct 7:3 FTCA as a substrate for beta oxidation (Butt et al., 2014). PFOA 
can then further degrade into short-chain compounds, such as HFBA, PFPeA, PFHxA, and 
PFHpA. PFOS can degrade into PFBS and HFBA (Huang and Jaffé, 2019). After treatment, PFAS 
are separated into sludge and effluent depending on their hydrophobicity. Hydrophobic long-
chain PFAS compounds are attracted to sludge as they are repelled by water, while hydrophilic 
short-chain PFAS compounds are attracted to water and remain in the effluent. All these 
examples offer an explanation for the significant increase in PFHxA observed. First, PFHxA is 
one of the short-chain PFAS compounds that is produced as a result of PFOA degradation, 
which is suggested to be the driving pathway of PFAS degradation and formation during 
biological treatment. It is also a short-chain PFAS compounds, indicating that it is hydrophilic, so 
it would likely stay in the effluent rather than bind to the sludge. The same reasoning applies to 
why polyfluoroalkyl compounds like 6:2 FTS are not present in the effluent. They may be either 
broken down during biological treatment to form PFOA, or they may bind to the sludge dueto 
being hydrophobic, which would cause them to be undetected in the effluent. Since PFOA 
seems to be degraded into short-chain compounds like PFHxA, it would be expected to have a 
small concentration in the effluent. Despite this, PFOA increased from influent to effluent, and 
had an effluent mean of about 17 ng/L, which is about a third of the effluent PFHxA 
concentration. While the PFOA concentration was less than PFHxA, it was still higher than 
expected. 
4.3 Comparison to Tavasoli study 
 Both the Great Bay and this study share sampled PFAS compounds. For PFCA 
compounds, both studies investigated PFBA, PFPeA, PFHxA, PFHpA, PFOA, PFNA, PFDA, PFUnA, 
PFDoA, and PFTrDA. For PFSA compounds, both studies investigated PFBS, PFHxS, PFOS, and 
PFDS. For precursor compounds, both studies examined 6:2 FTS. Both studies observed 
increases in PFBA when detected across all processes, with only 1 decrease in the Tavasoli study 
and two in this study. PFPeA showed a similar trend to PFBA for both studies. PFHxA, the only 
compound which changed significantly in this study, was detected in both at every location, and 
an increase was also observed at each facility. PFHpA was detected in all of the plants in the 
Tavasoli study, while it was only detected at two of the plants sampled by NHDES. For PFOA, 
similar results to PBFA were again seen. PFNA and PFDA were not detected in the Great Bay 
study, but were detected in 2 and 1 of the plants respectively in this study, with each detection 
showing an increase. Neither PFUna, PFDoA, nor PFTrDA were detected at any of the facilities in 
either study. PFBS increased at three of the four plants it was detected at in the Tavasoli study 
and followed an identical trend in this study. In the Great Bay study, PFHxS was detected at 
each facility and at four of the six facilities, it decreased in March and increased in July. PFHxS 
was only detected in five of the thirteen WWTPs, with a single plant observing an increase. 
PFOS was detected in every facility in the Tavasoli study, and followed the same pattern as 
PFHxS, but was reversed, with March showing increases and July showing decreases. In this 
study, PFOS was detected in 12 of the thirteen plants and decreased in eight of them. PFDS was 
detected in three plants and increased at two of them in the first study but was not detected in 
this study at any location. 6:2 FTS was detected at three of the Great Bay plants, increased at 
one, and was only detected at one plant sampled by NHDES, where it decreased. 
 The four PFAS regulated by the state of New Hampshire: PFOS, PFOA, PFHxS, and PFNA, 
increased at five plants and decreased at eight. The total PFAS concentration increased at 
eleven plants and decreased at two. This point supports the proposition that PFAS 
concentrations increase after biological treatment, as a majority of the plants tested reported 
it. The two where the concentration decreased were not using the same type of treatment or 
disinfection, which supports the idea that overall PFAS removal, or lack thereof, is not 
dependent on the secondary treatment process at each facility. 
The two studies had fairly similar results, as most of the shared PFAS compounds were detected 
and showed a similar change between influent and effluent.  
One aspect of the Tavasoli study which was not seen in this study was the impact of 
seasonal effects on PFAS concentrations in the effluent. For most of the compounds studied, it 
was found that there was not a correlation in the time of year resulting in an increase or 
decrease at most of the plants. For PFHxS and PFOS, there was a strong pattern present which 
suggests that the time of year may have had an impact on the concentrations of these PFAS in 
the effluent. The pattern showed that PFHxS decreased in March and increased in July, while 
PFOS did the opposite. These results occurred at the same four plants. In addition, the two 
plants not part of this pattern saw decreases for PFHxS and increases in PFOS. This information 
supports that PFHxS and PFOS effluent concentrations may differ seasonally due to different 
degradation pathways taken during biological treatment. This seasonal difference is possibly 
due to changes in temperature altering the conditions and causing a different microbial 
pathway to be used. The pathway used in March may cause the degradation of PFHxS and 
production of PFOS, while the pathway in July may involve the degradation of PFOS and the 
production of PFHxS. While this study did not address how seasons can affect biological 
treatment processes and effluent PFAS concentrations, as there were only individual samples 
available in the NHDES data set, it is likely that a similar trend may be seen at the NHDES 
sampled plants if sampled in March and July like the Tavasoli study. 
 
5. CONCLUSION AND RECOMMENDATIONS 
This study assessed how biological treatment at wastewater treatment plants in New 
Hampshire affected PFAS concentrations in the treated effluent. The dataset from the New 
Hampshire Department of Environmental Services contained influent and effluent 
concentrations of 16 PFAS for 13 WWTPS. The data was tested for significance for both influent 
versus effluent concentrations and removal or increase by four treatment types. The results 
were also compared to a study done by Elham Tavasoli. The study found that the only 
significant result was that the PFHxA concentration had a significant increase between the 
influent and effluent. Possible reasons for this observation may be due to a biodegradation 
pathway which produces short chain compounds like PFHxS, and the hydrophobicity or 
hydrophilicty of the compounds, as it will determine whether the PFAS compound is sorted into 
the effluent or the sludge. None of the tests by treatment type were significant, nor were there 
any noticeable trends in the data. Both the NHDES dataset as well as the data from the Tavasoli 
study mostly agreed, with increases and decreases being mirrored in both studies, apart from a 
single outlier. In addition, the time of year was shown to have a mild impact, as it only seemed 
to effect PFHxS and PFOA. 
Future recommendations are to use the same method with a larger dataset, as there 
were high standard deviations and some treatment types had only two data points to be 
compared. It is likely that more tests would show significance with a larger dataset, as the 
overall trend still showed an increase between influent and effluent for all but three of the 
compounds included in this study. The small sample size was a consistent problem throughout 
the study. Another suggestion would be to take seasonal samples, as the Tavasoli study 
supports that some PFAS compounds, such as PFHxS and PFOS, may either increase or decrease 
based on the time of year. It would be beneficial to test for seasonal differences using a larger 
dataset. Testing facilities which accept and do not accept landfill leachate would be useful, as it 
would help to identify if leachate accepting facilities differ from those which do not accept. 
Finally, testing both the effluent and sludge of these facilities would be a good method for 















A.1. Sampling location JMP output 
 
 
Figure A.1.1: JMP output for the ANOVA and Wilcoxon tests for 6:2 FTS, PFBS, and PFBA of PFAS 
concentration by sampling location 
 
 
Figure A.1.2: JMP output for the ANOVA and Wilcoxon tests for PFHpA, PFHxS, and PFHxA of 
PFAS concentration by sampling location. PFHxA had a significant p value for both tests. 
 
 
Figure A.1.3: JMP output for the ANOVA and Wilcoxon tests for PFOA, PFOS, and PFBA of PFPEA 
concentration by sampling location 
 
 
Figure A.1.4: JMP output for the ANOVA and Wilcoxon tests for total PFAS, total NH regulated 







A.2. Treatment process JMP output 
  
Figure A.2.1: JMP output for the ANOVA and Wilcoxon tests for PFBS and PFBA of PFAS 
concentration change by treatment process 
  
Figure A.2.2: JMP output for the ANOVA and Wilcoxon tests for PFHpA, PFHxS, and PFHxA of 
PFAS concentration change by treatment process 
  
Figure A.2.3: JMP output for the ANOVA and Wilcoxon tests for PFOA, and PFOS of PFPEA 
concentration change by treatment process 
 
Figure A.2.4: JMP output for the ANOVA and Wilcoxon tests for total PFAS and total NH 










A.3. NHDES Dataset 
 


















6:2 FTS PFBS PFBA PFDS PFDA PFDOA PFHPA PFHXS PFHXA PFNA PFTRDA PFOSA PFOA PFOS PFPEA PFTEDA PFUNA Total 
PFAS
Total of NH DW Regulated PFAS 
Compounds (PFOA, PFOS, PFNA, 
PFHXS)
C4-S C4 C10 C10 C12 C7 C6-S C6 C9 C13 C8 C8 C5 C14
Claremont 
Influent
Influent AS DC 6/13/17 <4 13 <4 <4 <4 <4 <4 7 <4 <4 <4 6 6 5 <4 <4 38 12
Claremont 
Effluent
Effluent AS DC 6/13/17 <4 7 <4 <4 <4 <4 <4 46 <4 <4 <4 6 7 21 <4 <4 86 13
Concord 
Influent
Influent ABF DC 6/19/17 <4 <4 <4 <4 <4 <4 <4 13 <4 <4 <4 6 7 13 <4 <4 39 13
Concord 
Effluent
Effluent ABF DC 6/19/17 <4 <4 <4 <4 <4 <4 <4 17 <4 <4 <4 8 <4 16 <4 <4 41 8
Derry Influent Influent AL 4/13/16 <5 <5 <5 <5 <5 <5 7 9 <5 <5 <5 9 9 120 <5 <5 154 25
Derry Effluent Effluent AL 4/13/16 <5 12 <5 <5 <5 <5 <5 47 <5 <5 <5 15 9 9 <5 <5 92 24
Dover Influent Effluent AS UV 6/19/17 <4 <4 <4 <4 <4 <4 8 6 <4 <4 <4 7 22 6 <4 <4 50 38
Dover Effluent Influent AS UV 6/19/17 <4 <4 <4 <4 <4 <4 6 11 <4 <4 <4 11 10 16 <4 <4 53 26
Franklin 
Influent
Effluent AS UV 6/19/17 5 <4 <4 <4 <4 <4 <4 5 <4 <4 <4 <4 6 <4 <4 <4 15 6
Franklin 
Effluent
Influent AS UV 6/19/17 4 <4 <4 <4 <4 <4 <4 18 <4 <4 <4 4 4 5 <4 <4 35 9
Jaffrey Influent Effluent AL UV 6/13/17 <4 <4 <4 <4 <4 <4 4 <4 <4 <4 <4 <4 14 <4 <4 <4 18 18
Jaffrey Effluent Influent AL UV 6/13/17 <4 <4 <4 <4 <4 <4 <4 6 <4 <4 <4 11 <4 16 <4 <4 33 11
Keene Influent Influent AS N/UV 6/13/17 <4 6 <4 <4 <4 <4 <4 4 <4 <4 <4 <4 <4 <4 <4 <4 10 0
Keene Effluent Effluent AS N/UV 6/13/17 <4 12 <4 <4 <4 <4 <4 52 <4 <4 <4 7 <4 73 <4 <4 144 7
Manchester 
Influent








































Influent AS TF 6/20/17 <4 56 <4 <4 <4 8 <4 49 <4 <4 <4 50 4 36 <4 <4 203 54
Merrimack 
Effluent
Effluent AS TF 6/20/17 <4 73 <4 <4 <4 19 <4 195 <4 <4 <4 49 <4 101 <4 <4 437 49
Milford 
Influent
Influent AS N/UV 6/13/17 <4 <4 <4 <4 <4 <4 <4 4 <4 <4 <4 6 <4 <4 <4 <4 10 6
Milford 
Effluent
Effluent AS N/UV 6/13/17 <4 <4 <4 4 <4 <4 <4 10 <4 <4 <4 10 14 7 <4 <4 45 24
Peterborough 
Infuent
Influent AL 8/8/17 32 <2.26 21 <2.26 <2.26 <2.26 <2.26 17 27 <2.26 <2.26 <2.26 3 <2.26 9 <2.26 <2.26 76 19
Peterborough 
Effluent
Effluent AL 8/8/17 13 2 19 <2.26 <2.26 <2.26 20 9 61 3 <2.26 <2.26 9 4 43 <2.26 <2.26 170 25
Rochester 
Influent
Influent AL DC 6/19/17 4 5 <4 <4 <4 15 6 26 <4 <4 <4 53 20 13 <4 <4 143 79
Rochester 
Effluent
Effluent AL DC 6/19/17 5 12 <4 <4 <4 14 6 65 4 <4 <4 54 14 57 <4 <4 232 78
Somersworth 
Influent
Influent EA DC 6/19/17 <4 23 <4 <4 <4 <4 <4 6 <4 <4 <4 <4 10 <4 <4 <4 38 10
Somersworth 
Effluent
Effluent EA DC 6/19/17 5 <4 <4 <4 <4 <4 <4 26 <4 <4 <4 7 <4 10 <4 <4 47 7
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